Skip to navigation
Skip to content
Search:
Home
Technology
Science
Environment
Culture
News Briefs
Israeli Biotech Startup SpliSense Raises $28M For Cystic Fibrosis Therapeutics
Founded in 2016, SpliSense created a platform that harnesses Anti Sense Oligonucleotides (ASO) to treat genetic diseases such as CF.
News Briefs
May 17, 2021
Skip to content
Open toolbar
Accessibility Tools
Accessibility Tools
Increase Text
Increase Text
Decrease Text
Decrease Text
High Contrast
High Contrast
Negative Contrast
Negative Contrast
Light Background
Light Background
Links Underline
Links Underline
Reset
Reset
Thank You for 14 Wonderful Years!
We’re pausing new activities but invite you to explore our archive of articles on Israeli innovation. Thank you for being part of our journey!
